BriaCell Therapeutics Announces $27.2M Private Placement
BriaCell Therapeutics Corp. (NASDAQ:BCTX, BCTXW))))(TSXV:BCT) (the "Company" or "BriaCell"), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer,